Cytokinetics

+$0.97 (+2.50%) Today
$0.00 (0.00%) As of 8:26 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cytokinetics and other ETFs, options, and stocks.

About CYTK

Cytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining. The firm is developing small molecule drug candidates specifically engineered to impact muscle function and contractility.

CEO
Robert I. Blum
Employees
253
Headquarters
South San Francisco, California
Founded
1997

CYTK Key Statistics

Market cap
3.41B
Price-Earnings ratio
—
Dividend yield
—
Average volume
1.04M
High today
$39.85
Low today
$38.05
Open price
$39.23
Volume
707.47K
52 Week high
$47.90
52 Week low
$17.72

CYTK News

MarketWatchMay 17

Cytokinetics: FDA Reverses Course, Plans AdCom Meeting on Omecamtiv Mecarbil - MarketWatch

By Colin Kellaher Cytokinetics Inc. on Tuesday said the U.S. Food and Drug Administration now plans to hold an advisory committee meeting on the company's prop

CYTK Earnings

-$1.02
-$0.68
-$0.34
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 4, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure